Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
The Nasdaq Composite Index ( ^IXIC -4.00%) is now squarely in correction territory. But stock market corrections have one key ...
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
Summit Therapeutics stock is off to a slow start in 2025, but it still trades at a massive $13 billion valuation. The biotech ...
3 Magnificent Growth Stocks to Buy in March
What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...
Inc10d
The Stock Market Is Suddenly Treating Trump’s Tariffs Like a Real Threat
Two weeks ago, I wrote a column titled “The Stock Market Isn’t Convinced Trump Is Serious About Tariffs.” I argued in the piece that investors were acting like the president was bluffing. The S&P 500 ...
Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
On March 5, 2025, Denali Therapeutics ( DNLI) Inc. provided an update that further analyses from Regimen G of the Phase 2/3 HEALEY ALS Platform Trial evaluating eIF2B agonist DNL343 in the treatment ...